Hawaii House Bill HR147

Hawaii 2022 Regular Session

• Introduced: 3/11/22
• Refer: 3/14/22

Caption

Requesting That The Drug Enforcement Administration Assist The Hawaii Department Of Health With Obtaining A Federal Exemption For The State Authorized Use Of Cannabis In Hawaii.

Impact

The resolution reflects a broader trend of states asserting their rights to regulate cannabis independently, particularly in light of the federal government's inconsistent stance. If the DEA were to grant the requested exemption, it would allow for smoother implementation of cannabis laws within the state, giving local health authorities more control over the program while mitigating fears that compliance with federal regulations might harm state efforts.

Summary

House Resolution 147 requests that the Drug Enforcement Administration (DEA) assist the Hawaii Department of Health in obtaining a federal exemption for the state's authorized use of cannabis. This resolution underscores the ongoing conflict between state and federal cannabis regulations, which has significant implications for licensed dispensaries and registered patients in Hawaii. The resolution was proposed as a response to the detrimental effects of federal restrictions on Hawaii's medical cannabis program, which has faced operational uncertainties due to conflicting laws.

Contention

Despite the bipartisan support for state-controlled cannabis programs, concerns remain regarding potential repercussions from the federal government, particularly the potential for enforcement actions against state programs. The Hawaii Department of Health has been hesitant to move forward with federal exemption requests, fearing that it might trigger negative responses from federal regulators, which reflects the complex legal landscape surrounding cannabis in the U.S. The ongoing conflict highlights the need for clearer federal guidelines and a comprehensive approach to cannabis regulation.